Synfine Drugs Private Limited
Pharmaceutical trading company incorporated in 2017 with registered office in Telangana.
2017 | Medak, Telangana (India) | Active
Synfine Drugs Profile
Key Indicators
- Authorised Capital ₹ 11.00 Cr
- Paid Up Capital ₹ 4.87 Cr
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.00 Cr
- Satisfied Charges ₹ 9.51 Cr
- Revenue Growth 12.49%
- Profit Growth 2472.93%
- Ebitda 57.31%
- Net Worth 29.72%
- Total Assets -18.77%
About Synfine Drugs
Synfine Drugs Private Limited (SDPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 March 2017 (Eight years and one month 25 days old ). Its registered office is in Medak, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 4.87 Cr.
The company currently has active open charges totaling ₹11.00 Cr. The company has closed loans amounting to ₹9.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Saida Battu and Chandra Battu serve as directors at the Company.
Company Details
- Location
Medak, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24304TG2017PTC116006
- Company No.
116006
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Synfine Drugs Private Limited
Explore comprehensive data for Synfine Drugs Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Synfine Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saida Battu  | Managing Director | 20-Mar-2017 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandra Battu | Director | 20-Mar-2017 | Current |
Financial Performance of Synfine Drugs.
Synfine Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.49% increase. The company also saw a substantial improvement in profitability, with a 2472.93% increase in profit. The company's net worth Soared by an impressive increase of 29.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synfine Drugs?
In 2023, Synfine Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Syn - Finechem Laboratories Private Limited
Saida Battu and Chandra Battu are mutual person
- Shankar Wires Pvt.Ltd.
Saida Battu and Chandra Battu are mutual person
Charges (Loans)
Open Charges
₹11.00 Cr
Satisfied Charges
₹9.51 Cr
Charges Breakdown by Lending Institutions
- Others : 11.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2024 | Others | ₹2.00 Cr | Open |
| 21 Nov 2024 | Others | ₹9.00 Cr | Open |
| 04 Sep 2019 | State Bank Of India | ₹9.51 Cr | Satisfied |
How Many Employees Work at Synfine Drugs?
Synfine Drugs has a workforce of 21 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synfine Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synfine Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Synfine Drugs
Recent activity within the organization
- Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101021956 was registered on 21 Nov 2024.
- Charges
A charge with Others amounted to Rs. 9.00 Cr with Charge ID 101022083 was registered on 21 Nov 2024.
- Charges
A charge registered on 04 Sep 2019 via Charge ID 100290357 with State Bank Of India was fully satisfied on 18 Nov 2024.
- Annual General Meeting
Synfine Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Synfine Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Charges
A charge with State Bank Of India of Rs. 9.51 Cr registered on 04 Sep 2019 with Charge ID 100290357 was modified on 07 Jun 2023.
Frequently asked questions
What is the Incorporation or founding date of Synfine Drugs Private Limited?
Synfine Drugs Private Limited was incorporated on 20 Mar 2017.
What is authorized share capital and paid-up capital of Synfine Drugs Private Limited?
The authorized share capital of Synfine Drugs Private Limited is ₹ 11.00 Cr and paid-up capital is ₹ 4.87 Cr.
Who are the current board members & directors of Synfine Drugs Private Limited?
Currently 2 directors are associated with Synfine Drugs Private Limited.
- Saida Reddy Battu
- Chandra Kala Battu
What is the registered address of Synfine Drugs Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Synfine Drugs Private Limited is Survey No 637 Temple Road, Bonthapally (Village) Gummadidala (Mandal) India, Sangareddy, Telangana, 502313.
What is the corporate identification number (CIN) and company number of Synfine Drugs Private Limited?
The corporate identification number (CIN) of Synfine Drugs Private Limited is U24304TG2017PTC116006 and the company number is 116006 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Synfine Drugs Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Synfine Drugs Private Limited has risen by 12.49%.
How many employees does Synfine Drugs Private Limited currently have?
As Per 2023 financial reports, 21 employees are currently employed by Synfine Drugs Private Limited.
What change has been observed in the net worth of Synfine Drugs Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Synfine Drugs Private Limited has experienced an upsurge of 29.72%.
What are the total open charges for Synfine Drugs Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Synfine Drugs Private Limited amount to ₹ 11.00 Cr.
When was the last Balance Sheet of Synfine Drugs Private Limited filed with the ROC?
The most recent Balance Sheet for Synfine Drugs Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records